Polynovo Ltd (ASX:PNV) is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology.
Australian medical device company PolyNovo Ltd (ASX: PNV) has released its first-half result to the market, but the PolyNovo share price remains effectively unchanged. Here’s my take on PolyNovo’s results.
The Polynovo Ltd (ASX:PNV) share price is up around 7% after announcing European growth.
In just a few weeks, nearly $1 billion has been wiped from the market capitalisation of medical device manufacturer PolyNovo Ltd (ASX:PNV). Are shares cheap today?
The S&P/ASX 200 (INDEXASX:XJO) is expected to open slightly lower on Wednesday. Altium (ASX:ALU) and PolyNovo (ASX:PNV) shares are in the news.
The Polynovo Ltd (ASX:PNV) share price is down 6% in early trading after giving a HY21 update.
Two key sectors that I’ll be researching for growth opportunities in 2021 are healthcare and technology. Here are two I’ll be watching closely next year.
Shares in wound care treatment provider PolyNovo Ltd (ASX: PNV) have gone on a rampage these last few months. Are PolyNovo shares a buy at today’s levels?
With around 2,185 stocks on the ASX, I’ve narrowed it down to three ASX growth shares I’m really liking at the moment.
Polynovo Ltd (ASX:PNV) shares are on watch today after the company announced expansion in Europe.
